Juan Jesús
Cruz Hernández
Profesor Emérito Honorífico
![Foto de Juan Jesús](/img/uploaded/6bc762c494c7f3c45062d2723e4f76f3.jpg)
![Foto de Complejo Asistencial Universitario de Burgos](/img/noimage_org.png)
Complejo Asistencial Universitario de Burgos
Burgos, EspañaPublicaciones en colaboración con investigadores/as de Complejo Asistencial Universitario de Burgos (10)
2022
2021
-
Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial
Clinical and Translational Oncology, Vol. 23, Núm. 4, pp. 764-772
2020
-
Oncogenic driver mutations predict outcome in a cohort of head and neck squamous cell carcinoma (HNSCC) patients within a clinical trial
Scientific Reports, Vol. 10, Núm. 1
2018
-
First-line treatment outcomes according to cfDNA analysis of RAS mutation status in metastatic colorectal cancer (mCRC) patients (pts): PERSEIDA study
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii183
2016
-
A Phase 2 Open Label, Single-Arm Trial to Evaluate the Combination of Cetuximab Plus Taxotere, Cisplatin, and 5-Flurouracil as an Induction Regimen in Patients with Unresectable Squamous Cell Carcinoma of the Head and Neck
International Journal of Radiation Oncology Biology Physics, Vol. 94, Núm. 2, pp. 289-296
2014
-
A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer
Annals of Oncology, Vol. 25, Núm. 1, pp. 216-225
2013
-
Incidence of -93 MLH1 promoter polymorphism in familial and sporadic colorectal cancer
Colorectal Disease, Vol. 15, Núm. 3
-
SEOM recommendations on the structure and operation of hereditary cancer genetic counseling units (HCGCUs)
Clinical and Translational Oncology, Vol. 15, Núm. 1, pp. 20-25
2005
-
Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5- fluorouracil for locally advanced squamous cell carcinoma of the head and neck: A randomised phase II study
European Journal of Cancer, Vol. 41, Núm. 9, pp. 1254-1260
2003
-
A multicenter phase II study of irinotecan in patients with advanced colorectal cancer previously treated with 5-fluorouracil
Clinical Colorectal Cancer, Vol. 3, Núm. 3, pp. 174-179